Chlamydia trachomatis

The firm said that its Cobas CT/NG real-time PCR assay is the first available in the US for the testing of sexually transmitted infections on its 6800 and 8800 systems.

The company said it will use the funds to expand its menu of STI tests and launch its io rapid diagnostic platform into UK sexual health clinics.

In Genome Research this week: population genomics and genome dynamics of Chlamydia, non-coding mutation found in microcephaly-micromelia syndrome, and more.

The funding comes from a syndicate which includes all Series C investors and one new investor, Chinese assay developer Wondfo Biotech.

Sequences from Chlamydia trachomatis strains in northern Australia suggest trachoma infections in the eye may be caused by small changes to urogenital strains.

Becton Dickinson said this week that it has received US Food and Drug Administration clearance to market BD Max StaphSR Assay for use on the BD Max automated molecular testing system.

NEW YORK (GenomeWeb News) – By turning to a simultaneous RNA-seq strategy, researchers at the University of Maryland School of Medicine profiled the transcriptomes of Chlamydia trachomatis and the host cells the bacteria infected, gaining a glimpse into how disease is established and cau

NEW YORK (GenomeWeb News) – Roche announced today that the US Food and Drug Administration has granted 510(k) clearance for four additional specimen types for use with the firm's cobas CT/NG v2.0 test, which helps physicians diagnose Chlamydia trachomatis and Neisseria gonorrhoeae

A flurry of recently published peer-reviewed papers has demonstrated the growing breadth and diversity of applications for Bio-Rad's QX100 Droplet Digital PCR system.

Using a combination of immunomagnetic separation and multiple displacement amplification, or IMS-MDA, a team led by researchers at the Wellcome Trust Sanger Institute has developed a method allowing sequencing of whole genomes from discarded molecular diagnostics samples, without

Pages

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.